IMMUNOSUPRESSIVE THERAPY AND RENAL SURVIVAL IN MESANGIPROLIFERATIVE GLOMERULONEPHRITIS WITH PROTEINURIA/HEMATURIA
- Authors: Batanina NY.1, Duman VL1
-
Affiliations:
- Issue: No 6 (2010)
- Pages: 61-65
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/245972
- ID: 245972
Cite item
Full Text
Abstract
Aim. To assess the reasonability of immunosuppressive therapy with cyclophposphamide of mesangioproliferative glomerulonephritis with proteinuria/haematuria.
Methods. 112 patients with mesangioproliferative glomerulonephritis with proteinuria/haematuria (mean age 25,0±8,2 years, mean duration of kidney disease - 11,3±5,3 years) were included into the study. 23 patients received immunosuppressive therapy: 2 - monotherapy with corticosteroids, 6 - monotherapy with cyclophosphamide, 15 - combination of corticosteroids and cyclophosphamide.
Results. In 21 patients immunosuppressive therapy with corticosteroids and cyclophosphamide improved renal survival in presence of glomerulonephritis activity: proteinuria ≥0,5 g/l, haematuria ≥50 erythrocytes in vision view, elevation of seromucoid level ≥0,210 units, hyperfibrinogenemis ≥4,0 g/l, histological activity index ≥21 and/or total sclerosis index ≥8.
Conclusion. Immunosupressive therapy can be indicated in patients with mesangioproliferative glomerulonephritis in presence of signs of glomerulonephritis activity.
Methods. 112 patients with mesangioproliferative glomerulonephritis with proteinuria/haematuria (mean age 25,0±8,2 years, mean duration of kidney disease - 11,3±5,3 years) were included into the study. 23 patients received immunosuppressive therapy: 2 - monotherapy with corticosteroids, 6 - monotherapy with cyclophosphamide, 15 - combination of corticosteroids and cyclophosphamide.
Results. In 21 patients immunosuppressive therapy with corticosteroids and cyclophosphamide improved renal survival in presence of glomerulonephritis activity: proteinuria ≥0,5 g/l, haematuria ≥50 erythrocytes in vision view, elevation of seromucoid level ≥0,210 units, hyperfibrinogenemis ≥4,0 g/l, histological activity index ≥21 and/or total sclerosis index ≥8.
Conclusion. Immunosupressive therapy can be indicated in patients with mesangioproliferative glomerulonephritis in presence of signs of glomerulonephritis activity.
References
- Камерон Дж.С. Лечение гломерулонефрита и васкулита. Международный семинар по нефрологии. М., 1995, 91-98
- Панферова Р.Д., Богдан Г.М., Прудникова Г.В., Скрябина И.А. Некоторые данные о распространенности хронической почечной недостаточности в Иркутской области. Нефрологический семинар′98: Сб. труд. IV ежегод. Санкт-Петербургского нефрологического семинара . СПб.: РЕНКОР,1998, 163-164
- Дядык А.И., Дикштейн Е.А., Василенко И.В. и др. Клинико-лабораторная характеристика и эффективность глюкокортикоидной терапии больных первичным диффузным мезангиопролиферативным гломерулонефритом. Тер. арх. 1987; 59(8): 35-37
- Рябов С.И., Ставская В.В. Течение различных клинических форм гломерулонефрита. Тер. арх. 1984; 56(7): 20-23
- Шулутко Б.И. Соотношение различных форм первичного гломерулонефрита в современных условиях и их диагностические критерии (опыт работы нефрологического отделения, клинико-морфологический анализ 3000 наблюдений). Тер. арх . 1992; 64(6): 40-43
- Тареева И.Е., Серов В.В., Варшавский В.А., Калиев Р. Особенности течения и прогноз различных морфологических форм хронического гломерулонефрита. Тер. арх. 1981; 53(6): 10-14
- Шулутко Б.И. Патология почек: клинико-морфологическое исследование. Л.: Медицина, 1983
- d'amico G. The commonest glomerulonephritis in the world: IgA nephropathy Q. J. Med. 1987; 64: 709-727
- Julian B.A. Treatment of IgA nephropathy. Semin. Nephrol. 2000; 20(3): 277-285
- Feehally J. Immunoglobulin A nephropathy: fish oils and beyond. Curr. Opin. Nephrol. Hypertens. 1996; 5(5): 442-446
- Pozzi C., Del Vecchio L., Locatelli F. Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review. G. Ital. Nefrol. 2002; 19(5): 523-528
- Tsuruya K., Harada A., Hirakata H. et al. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy. Clin. Nephrol. 2000; 53(1): 1-9
- Chen K.J., Cheng C.H., Wu M.J. et al. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes. J. Chin. Med. Assoc . 2003; 66(5): 263-270
- Faedda R., Pirisi M., Satta A. et al. Immunosuppressive treatment of Berger's disease Clin. Pharmacol. Ther. 1996; 60(5): 561-567
- Oshima S., Kawamura O. Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy. Clin. Exp. Nephrol. 2008; 12(4): 264-269.
Supplementary files
